Nigel Crockett Bicycle Therapeutics PLC (BCYC) insider trading activity

Nigel Crockett is CHIEF BUSINESS OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 51,053 shares of BCYC, which is worth approximately $673,899. The most recent transaction as insider was on Jan 03, 2025, when has been sold 936 shares (Ordinary Shares) at a price of $14.75 per share, resulting in proceeds of $13,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.1K

11.42% 3M change

4.8% 12M change

Total Value Held $673,899

Nigel Crockett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2025	SELL Open market or private sale	$13,806 $14.75 p/Share	936 Reduced 1.8%	51,053 Ordinary Shares
Jan 02 2025	SELL Open market or private sale	$36,394 $14.09 p/Share	2,583 Reduced 4.73%	51,989 Ordinary Shares
Jan 02 2025	BUY Grant, award, or other acquisition	-	8,750 Added 13.82%	54,572 Ordinary Shares
Oct 03 2024	SELL Open market or private sale	$21,636 $22.26 p/Share	972 Reduced 2.08%	45,822 Ordinary Shares
Jul 03 2024	SELL Open market or private sale	$18,991 $19.64 p/Share	967 Reduced 2.02%	46,794 Ordinary Shares
Apr 03 2024	SELL Open market or private sale	$22,738 $23.81 p/Share	955 Reduced 1.96%	47,761 Ordinary Shares
Jan 03 2024	SELL Open market or private sale	$46,252 $17.5 p/Share	2,643 Reduced 5.15%	48,716 Ordinary Shares
Jan 02 2024	BUY Grant, award, or other acquisition	-	22,000 Added 29.99%	51,359 Ordinary Shares
Oct 03 2023	SELL Open market or private sale	$8,840 $20.0 p/Share	442 Reduced 1.48%	29,359 Ordinary Shares
Jul 03 2023	SELL Open market or private sale	$11,320 $25.1 p/Share	451 Reduced 1.49%	29,801 Ordinary Shares
Apr 03 2023	SELL Open market or private sale	$9,436 $21.11 p/Share	447 Reduced 1.46%	30,252 Ordinary Shares
Jan 03 2023	SELL Open market or private sale	$52,337 $29.06 p/Share	1,801 Reduced 5.54%	30,699 Ordinary Shares
Jan 03 2023	BUY Grant, award, or other acquisition	-	17,500 Added 35.0%	32,500 Ordinary Shares
Jan 03 2022	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Ordinary Shares
Jul 13 2021	SELL Open market or private sale	$2,380,958 $32.75 p/Share	72,701 Reduced 100.0%	0 Ordinary Shares
Jul 13 2021	BUY Exercise of conversion of derivative security	$892,768 $12.28 p/Share	72,701 Added 50.0%	72,701 Ordinary Shares
Jul 12 2021	SELL Open market or private sale	$225,107 $32.03 p/Share	7,028 Reduced 100.0%	0 Ordinary Shares
Jul 12 2021	BUY Exercise of conversion of derivative security	$86,304 $12.28 p/Share	7,028 Added 50.0%	7,028 Ordinary Shares
Jul 06 2021	SELL Open market or private sale	$8,672 $32.0 p/Share	271 Reduced 100.0%	0 Ordinary Shares
Jul 06 2021	BUY Exercise of conversion of derivative security	$2,661 $9.82 p/Share	271 Added 50.0%	271 Ordinary Shares

Nigel Crockett

CHIEF BUSINESS OFFICER

Cambridge, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Value

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC

Account